Atlas Trials

Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines

Clinical trial NCT01237977 · COMPLETED

Trial details

NCT number
NCT01237977
Sponsor
Medy-Tox
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Skin Aging
Start date
2009-11-23
Primary completion
2010-08-30
Enrollment
314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.